You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

SELFEMRA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Selfemra, and what generic alternatives are available?

Selfemra is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in SELFEMRA is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Selfemra

A generic version of SELFEMRA was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2nd, 2001.

  Try a Trial

Drug patent expirations by year for SELFEMRA
Recent Clinical Trials for SELFEMRA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityN/A

See all SELFEMRA clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for SELFEMRA

US Patents and Regulatory Information for SELFEMRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa SELFEMRA fluoxetine hydrochloride TABLET;ORAL 200151-001 Feb 3, 2014 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Pharms Usa SELFEMRA fluoxetine hydrochloride TABLET;ORAL 200151-002 Feb 3, 2014 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Pharms Usa SELFEMRA fluoxetine hydrochloride TABLET;ORAL 200151-003 Feb 3, 2014 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.